Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin

PURPOSE: The aim of this study is to analyze the outcomes of platinum-sensitive (PS) recurrent ovarian cancer treated with pegylated liposomal doxorubicin and carboplatin (CD) versus paclitaxel and carboplatin (CP). Clinical features were examined to characterize the patient population that would be...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Chia-Sui, Wu, Chao-Chih, Chen, Tze-Chien, Chen, Jen-Ruei, Huang, Chueh-Yi, Chang, Chih-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877447/
https://www.ncbi.nlm.nih.gov/pubmed/31819627
http://dx.doi.org/10.2147/CMAR.S217329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877447/
https://www.ncbi.nlm.nih.gov/pubmed/31819627
http://dx.doi.org/10.2147/CMAR.S217329

Ejemplares similares